169 related articles for article (PubMed ID: 16901051)
1. Anti-HLA antibodies after cryopreserved allograft valve implantation does not predict valve dysfunction at three-year follow up.
Yap CH; Skillington PD; Matalanis G; Davis BB; Tait BD; Hudson F; Ireland L; Nixon I; Yiil M
J Heart Valve Dis; 2006 Jul; 15(4):540-4. PubMed ID: 16901051
[TBL] [Abstract][Full Text] [Related]
2. Aortic valve allograft structural deterioration is associated with a subset of antibodies to human leukocyte antigens.
Dignan R; O'Brien M; Hogan P; Thornton A; Fowler K; Byrne D; Stephens F; Harrocks S
J Heart Valve Dis; 2003 May; 12(3):382-90; discussion 390-1. PubMed ID: 12803340
[TBL] [Abstract][Full Text] [Related]
3. Six-year monitoring of the donor-specific immune response to cryopreserved aortic allograft valves: implications with valve dysfunction.
Pompilio G; Polvani G; Piccolo G; Guarino A; Nocco A; Innocente A; Porqueddu M; Dainese L; Veglia F; Sala A; Biglioli P
Ann Thorac Surg; 2004 Aug; 78(2):557-63. PubMed ID: 15276519
[TBL] [Abstract][Full Text] [Related]
4. Human leukocyte antigen mismatch and other factors affecting cryopreserved allograft valve function.
Yap CH; Skillington PD; Matalanis G; Davis BB; Tait BD; Hudson F; Ireland L; Nixon I; Yii M
Heart Surg Forum; 2008; 11(1):E42-5. PubMed ID: 18270140
[TBL] [Abstract][Full Text] [Related]
5. A broad and strong humoral immune response to donor HLA after implantation of cryopreserved human heart valve allografts.
Welters MJ; Oei FB; Witvliet MD; Vaessen LM; Cromme-Dijkhuis AH; Bogers AJ; Weimar W; Claas FH
Hum Immunol; 2002 Nov; 63(11):1019-25. PubMed ID: 12392854
[TBL] [Abstract][Full Text] [Related]
6. Donor-specific anti-human leukocyte antigen class I antibodies after implantation of cardiac valve allografts.
Hoekstra F; Witvliet M; Knoop C; Akkersdijk G; Jutte N; Bogers A; Claas F; Weimar W
J Heart Lung Transplant; 1997 May; 16(5):570-2. PubMed ID: 9171278
[TBL] [Abstract][Full Text] [Related]
7. Anti-HLA antibodies and pulmonary valve allograft function after the Ross procedure.
Bechtel JF; Marquardt A; Müller-Steinhardt M; Hankel T; Stierle U; Sievers HH
J Heart Valve Dis; 2009 Nov; 18(6):673-80; discussion 681. PubMed ID: 20099717
[TBL] [Abstract][Full Text] [Related]
8. Panel-reactive antibodies late after allograft implantation in children.
Hooper DK; Hawkins JA; Fuller TC; Profaizer T; Shaddy RE
Ann Thorac Surg; 2005 Feb; 79(2):641-4; discussion 645. PubMed ID: 15680851
[TBL] [Abstract][Full Text] [Related]
9. Flow cytometric detection of HLA-specific antibodies as a predictor of heart allograft rejection.
Tambur AR; Bray RA; Takemoto SK; Mancini M; Costanzo MR; Kobashigawa JA; D'Amico CL; Kanter KR; Berg A; Vega JD; Smith AL; Roggero AL; Ortegel JW; Wilmoth-Hosey L; Cecka JM; Gebel HM
Transplantation; 2000 Oct; 70(7):1055-9. PubMed ID: 11045642
[TBL] [Abstract][Full Text] [Related]
10. Detection and analysis of HLA class I and class II specific alloantibodies in the sera of dialysis recipients waiting for a renal retransplantation.
Barocci S; Valente U; Nocera A
Clin Transplant; 2007; 21(1):47-56. PubMed ID: 17302591
[TBL] [Abstract][Full Text] [Related]
11. Class I and class II anti-HLA antibodies after implantation of cryopreserved allograft material in pediatric patients.
Hawkins JA; Breinholt JP; Lambert LM; Fuller TC; Profaizer T; McGough EC; Shaddy RE
J Thorac Cardiovasc Surg; 2000 Feb; 119(2):324-30. PubMed ID: 10649208
[TBL] [Abstract][Full Text] [Related]
12. HLA expression in aortic and pulmonary homografts: effects of cryopreservation.
Verghese S; Cherian KM
Indian Heart J; 2002; 54(4):394-8. PubMed ID: 12462667
[TBL] [Abstract][Full Text] [Related]
13. Influence of HLA matching and associated factors on aortic valve homograft function.
Dignan R; O'Brien M; Hogan P; Passage J; Stephens F; Thornton A; Harrocks S
J Heart Valve Dis; 2000 Jul; 9(4):504-11. PubMed ID: 10947042
[TBL] [Abstract][Full Text] [Related]
14. Effect of HLA mismatching and antibody status on "homovital" aortic valve homograft performance.
Smith JD; Hornick PI; Rasmi N; Rose ML; Yacoub MH
Ann Thorac Surg; 1998 Dec; 66(6 Suppl):S212-5. PubMed ID: 9930450
[TBL] [Abstract][Full Text] [Related]
15. Anti-HLA antibodies and kidney allograft outcomes in recipients with donor bone marrow cell infusion.
Solgi G; Pourmand G; Mehrsai A; Taherimahmoudi M; Nicknam MH; Ebrahimi Rad MR; Seraji A; Asadpoor A; Ansaripor B; Nikbin B; Amirzargar A
Iran J Immunol; 2010 Mar; 7(1):18-29. PubMed ID: 20371916
[TBL] [Abstract][Full Text] [Related]
16. Circulating donor-specific cytotoxic T lymphocytes with high avidity for donor human leukocyte antigens in pediatric and adult cardiac allograft valved conduit recipients.
Oei FB; Welters MJ; Knoop CJ; Vaessen LM; Stegmann AP; Weimar W; Bogers AJ
Eur J Cardiothorac Surg; 2000 Oct; 18(4):466-72. PubMed ID: 11024386
[TBL] [Abstract][Full Text] [Related]
17. Clinical relevance of pre and post-transplant immune markers in kidney allograft recipients: anti-HLA and MICA antibodies and serum levels of sCD30 and sMICA.
Solgi G; Furst D; Mytilineos J; Pourmand G; Amirzargar AA
Transpl Immunol; 2012 Mar; 26(2-3):81-7. PubMed ID: 22182633
[TBL] [Abstract][Full Text] [Related]
18. The presence of immune stimulatory cells in fresh and cryopreserved donor aortic and pulmonary valve allografts.
Oei FB; Stegmann AP; van der Ham F; Zondervan PE; Vaessen LM; Baan CC; Weimar W; Bogers AJ
J Heart Valve Dis; 2002 May; 11(3):315-24; discussion 325. PubMed ID: 12056721
[TBL] [Abstract][Full Text] [Related]
19. Immunogenic human leukocyte antigen class II antigens on human cardiac valves induce specific alloantibodies.
Hoekstra FM; Witvliet M; Knoop CY; Wassenaar C; Bogers AJ; Weimar W; Claas FH
Ann Thorac Surg; 1998 Dec; 66(6):2022-6. PubMed ID: 9930487
[TBL] [Abstract][Full Text] [Related]
20. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
Lee PC; Ozawa M
Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
